|
|
The role of ion channels and transporters in B cell function |
| 1F30AI164803-01A1 |
|
NIAID |
2022 |
|
|
Interrogating immune signatures in the thoracic duct of patients with multiple sclerosis |
| 1F31AI167501-01 |
|
NIAID |
2022 |
|
|
Investigation of enterovirus D68 pathogenesis in the human spinal cord |
| 1K08AI171177-01 |
|
NIAID |
2022 |
|
|
Deconstructing interactions between diet, microbiome, and immunity to gain mechanistic insight into health and disease |
| 1K99AI159227-01A1 |
|
NIAID |
2022 |
|
|
Targeting OCA-B in multiple sclerosis |
| 1R01AI162929-01A1 |
|
NIAID |
2022 |
|
|
CAR-T cell treatment of CNS Autoimmunity |
| 1R01AI165771-01A1 |
|
NIAID |
2022 |
|
|
Implant Biofilm Mediated Immune Response |
| 1R01AI165958-01A1 |
|
NIAID |
2022 |
|
|
Tissue-Specific Mechanisms of Regulatory T Cells in the CNS during Autoimmune Encephalomyelitis |
| 1R01AI168063-01 |
|
NIAID |
2022 |
|
|
Role of Natural Killer Cell Diversity in Multiple Sclerosis Risk and Disease Course |
| 1R01AI169070-01A1 |
|
NIAID |
2022 |
|
|
Metabolic regulators of Treg/Th17 balance in CNS autoimmunity |
| 1R01AI169075-01A1 |
|
NIAID |
2022 |